GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
Ipamorelin/CJC-1295 Blend 10mg v2

Ipamorelin/CJC-1295 Blend 10mg v2

Ipamorelin + CJC-1295

CAS: 170851-70-4 / 863288-34-0

$80.99$89.9910% OFFIn Stock

Ipamorelin/CJC-1295 Blend v2 — 5mg Ipamorelin + 5mg CJC-1295 No DAC. Alternative formulation of the classic GH axis dual-peptide stack. 99.0% HPLC purity.

Specifications

Ipamorelin5mg
CJC-12955mg
FormLyophilized Powder
Purity99.0% HPLC
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

CJC-1295 amplifies GH pulse amplitude via GHRH receptors. Ipamorelin increases GH pulse frequency via GHS-R1a. Combined pulsatile GH release exceeds either compound alone.

Research FAQ

How does this differ from the original CJC-1295/Ipamorelin blend?

Same compound ratios in an alternative formulation. Functionally equivalent — choose based on availability.

Related Compounds